Search research articles
Contact Us
Filters
Showing results (961-970 of 991) with videos related to
Page
of 100
Sort By:
Lancet (London, England)
|
July 23, 2019
Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
Walter R J Taylor, Kamala Thriemer, Lorenz von Seidlein, et al.
The Lancet. Child & Adolescent Health
|
September 27, 2024
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis
Robert J Commons, Megha Rajasekhar, Elizabeth N Allen, et al.
BMC Medicine
|
September 15, 2022
Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data
Kasia Stepniewska, Elizabeth N Allen, Georgina S Humphreys, et al.
Nature Ecology & Evolution
|
December 6, 2017
Local loss and spatial homogenization of plant diversity reduce ecosystem multifunctionality
Yann Hautier, Forest Isbell, Elizabeth T Borer, et al.
Plos Medicine
|
July 25, 2020
Correction: Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis
Daniel A Pfeffer, Benedikt Ley, Rosalind E Howes, et al.
Plos Medicine
|
May 15, 2020
Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis
Daniel A Pfeffer, Benedikt Ley, Rosalind E Howes, et al.
Antimicrobial Agents and Chemotherapy
|
June 27, 2018
UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria
Christel Brunschwig, Nina Lawrence, Dale Taylor, et al.
Malaria Journal
|
September 23, 2015
Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis
, Salim Abdulla, Elizabeth A Ashley, et al.
Science Translational Medicine
|
July 22, 2021
The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to <i>Plasmodium falciparum</i> parasite resistance
James M Murithi, Cécile Pascal, Jade Bath, et al.
Plos Medicine
|
November 19, 2020
The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network
Mohammad S Hossain, Robert J Commons, Nicholas M Douglas, et al.
Page
of 100
Search research articles
Search
Showing results (961-970 of 991) with videos related to
Sort By:
Page
of 100
Lancet (London, England)
|
July 23, 2019
Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
Walter R J Taylor, Kamala Thriemer, Lorenz von Seidlein, et al.
The Lancet. Child & Adolescent Health
|
September 27, 2024
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis
Robert J Commons, Megha Rajasekhar, Elizabeth N Allen, et al.
BMC Medicine
|
September 15, 2022
Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data
Kasia Stepniewska, Elizabeth N Allen, Georgina S Humphreys, et al.
Nature Ecology & Evolution
|
December 6, 2017
Local loss and spatial homogenization of plant diversity reduce ecosystem multifunctionality
Yann Hautier, Forest Isbell, Elizabeth T Borer, et al.
Plos Medicine
|
July 25, 2020
Correction: Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis
Daniel A Pfeffer, Benedikt Ley, Rosalind E Howes, et al.
Plos Medicine
|
May 15, 2020
Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis
Daniel A Pfeffer, Benedikt Ley, Rosalind E Howes, et al.
Antimicrobial Agents and Chemotherapy
|
June 27, 2018
UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria
Christel Brunschwig, Nina Lawrence, Dale Taylor, et al.
Malaria Journal
|
September 23, 2015
Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis
, Salim Abdulla, Elizabeth A Ashley, et al.
Science Translational Medicine
|
July 22, 2021
The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to <i>Plasmodium falciparum</i> parasite resistance
James M Murithi, Cécile Pascal, Jade Bath, et al.
Plos Medicine
|
November 19, 2020
The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network
Mohammad S Hossain, Robert J Commons, Nicholas M Douglas, et al.
Page
of 100